Literature DB >> 6357987

Influence of bradykinin on glucose uptake and metabolism studied in isolated cardiac myocytes and isolated perfused rat hearts.

P Rösen, J Eckel, H Reinauer.   

Abstract

To study whether bradykinin influences myocardial glucose metabolism as suggested for skeletal muscle, we studied the effect of bradykinin on myocardial glucose transport using isolated cardiac cells and on glucose metabolism using the isolated perfused rat heart. In isolated cardiac myocytes bradykinin alone had no influence on the initial velocity of basal glucose transport nor on the sensitivity of the glucose carrier towards stimulation by insulin. By contrast, in isolated perfused hearts bradykinin increased the rate of glucose uptake and oxidation as well as the formation of lactate independently of the action of insulin. In diabetic hearts, neither bradykinin nor insulin alone had a significant influence on myocardial glucose oxidation, however, both hormones together act synergistically to improve glucose oxidation. These data suggest that bradykinin enhanced the nutritional flow across the capillary wall and, thereby, indirectly accelerates the glucose metabolism in the isolated perfused heart. There is no evidence for a direct effect of bradykinin on the rate of glucose transport in the heart.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357987     DOI: 10.1515/bchm2.1983.364.2.1431

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  14 in total

1.  Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?

Authors:  P A Martorana; W Linz; B A Schölkens
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

Review 2.  The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.

Authors:  G Bönner
Journal:  Drugs       Date:  1997       Impact factor: 9.546

3.  Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.

Authors:  M Turcani; H Rupp
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

4.  Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.

Authors:  H Laine; H Yki-Jarvinen; O Kirvela; T Tolvanen; M Raitakari; O Solin; M Haaparanta; J Knuuti; P Nuutila
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

6.  Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.

Authors:  W Linz; B A Schölkens; J Kaiser; M Just; B Y Qi; U Albus; P Petry
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

7.  Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.

Authors:  W Linz; J Schaper; G Wiemer; U Albus; B A Schölkens
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

Review 8.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor.

Authors:  R Chahine; A Adam; N Yamaguchi; R Gaspo; D Regoli; R Nadeau
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

10.  Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography.

Authors:  P Nuutila; M Raitakari; H Laine; O Kirvelä; T Takala; T Utriainen; S Mäkimattila; O P Pitkänen; U Ruotsalainen; H Iida; J Knuuti; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.